nodes	percent_of_prediction	percent_of_DWPC	metapath
Protriptyline—ABCB1—esophageal cancer	0.864	1	CbGaD
Protriptyline—Paresthesia of limbs—Methotrexate—esophageal cancer	0.00426	0.0538	CcSEcCtD
Protriptyline—Inappropriate antidiuretic hormone secretion—Cisplatin—esophageal cancer	0.00256	0.0324	CcSEcCtD
Protriptyline—Ileus paralytic—Capecitabine—esophageal cancer	0.00253	0.0321	CcSEcCtD
Protriptyline—ABCB1—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00201	0.0386	CbGpPWpGaD
Protriptyline—CYP2D6—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00189	0.0364	CbGpPWpGaD
Protriptyline—Bone marrow depression—Capecitabine—esophageal cancer	0.00162	0.0205	CcSEcCtD
Protriptyline—CYP2D6—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.0015	0.0287	CbGpPWpGaD
Protriptyline—Body temperature increased—Carboplatin—esophageal cancer	0.00143	0.0181	CcSEcCtD
Protriptyline—Tingling sensation—Capecitabine—esophageal cancer	0.00136	0.0172	CcSEcCtD
Protriptyline—Petechiae—Capecitabine—esophageal cancer	0.00133	0.0169	CcSEcCtD
Protriptyline—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.00131	0.0252	CbGpPWpGaD
Protriptyline—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.00123	0.0237	CbGpPWpGaD
Protriptyline—Bone marrow depression—Methotrexate—esophageal cancer	0.00121	0.0153	CcSEcCtD
Protriptyline—Nocturia—Capecitabine—esophageal cancer	0.00118	0.0149	CcSEcCtD
Protriptyline—CYP2D6—CYP2E1 reactions—CYP2A6—esophageal cancer	0.00117	0.0225	CbGpPWpGaD
Protriptyline—Coordination abnormal—Capecitabine—esophageal cancer	0.00112	0.0141	CcSEcCtD
Protriptyline—SLC6A4—NRF2 pathway—ALDH3A1—esophageal cancer	0.00111	0.0213	CbGpPWpGaD
Protriptyline—Cerebrovascular accident—Cisplatin—esophageal cancer	0.0011	0.0139	CcSEcCtD
Protriptyline—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.0011	0.0211	CbGpPWpGaD
Protriptyline—Phenylbutazone—PTGS1—esophageal cancer	0.00109	0.209	CrCbGaD
Protriptyline—Carbamazepine—ABCC2—esophageal cancer	0.00103	0.197	CrCbGaD
Protriptyline—CYP2D6—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.001	0.0193	CbGpPWpGaD
Protriptyline—Petechiae—Methotrexate—esophageal cancer	0.000992	0.0125	CcSEcCtD
Protriptyline—SLC6A4—NRF2 pathway—BLVRB—esophageal cancer	0.000989	0.019	CbGpPWpGaD
Protriptyline—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000986	0.0125	CcSEcCtD
Protriptyline—SLC6A2—NRF2 pathway—ALDH3A1—esophageal cancer	0.000955	0.0183	CbGpPWpGaD
Protriptyline—CYP2D6—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.000925	0.0178	CbGpPWpGaD
Protriptyline—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000894	0.0172	CbGpPWpGaD
Protriptyline—Vascular purpura—Capecitabine—esophageal cancer	0.000889	0.0112	CcSEcCtD
Protriptyline—Pancytopenia—Cisplatin—esophageal cancer	0.000886	0.0112	CcSEcCtD
Protriptyline—CYP2D6—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.000869	0.0167	CbGpPWpGaD
Protriptyline—Libido decreased—Capecitabine—esophageal cancer	0.000858	0.0109	CcSEcCtD
Protriptyline—SLC6A2—NRF2 pathway—BLVRB—esophageal cancer	0.000851	0.0163	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—PRDX1—esophageal cancer	0.000841	0.0162	CbGpPWpGaD
Protriptyline—Purpura—Capecitabine—esophageal cancer	0.000826	0.0104	CcSEcCtD
Protriptyline—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00082	0.0104	CcSEcCtD
Protriptyline—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000818	0.0157	CbGpPWpGaD
Protriptyline—Myocardial infarction—Cisplatin—esophageal cancer	0.000815	0.0103	CcSEcCtD
Protriptyline—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000815	0.0103	CcSEcCtD
Protriptyline—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000812	0.0103	CcSEcCtD
Protriptyline—Stomatitis—Cisplatin—esophageal cancer	0.000811	0.0103	CcSEcCtD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—ADCYAP1—esophageal cancer	0.000798	0.0153	CbGpPWpGaD
Protriptyline—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000789	0.00998	CcSEcCtD
Protriptyline—Urinary retention—Capecitabine—esophageal cancer	0.000757	0.00957	CcSEcCtD
Protriptyline—SLC6A4—NRF2 pathway—SLC39A6—esophageal cancer	0.00075	0.0144	CbGpPWpGaD
Protriptyline—Ataxia—Capecitabine—esophageal cancer	0.000748	0.00946	CcSEcCtD
Protriptyline—Gynaecomastia—Methotrexate—esophageal cancer	0.00073	0.00923	CcSEcCtD
Protriptyline—CYP2D6—Xenobiotics—CYP2A6—esophageal cancer	0.000727	0.014	CbGpPWpGaD
Protriptyline—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000727	0.00919	CcSEcCtD
Protriptyline—SLC6A2—NRF2 pathway—PRDX1—esophageal cancer	0.000723	0.0139	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—ADH7—esophageal cancer	0.000715	0.0137	CbGpPWpGaD
Protriptyline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000709	0.0136	CbGpPWpGaD
Protriptyline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000709	0.0136	CbGpPWpGaD
Protriptyline—CYP2D6—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.000699	0.0134	CbGpPWpGaD
Protriptyline—Tinnitus—Cisplatin—esophageal cancer	0.000696	0.00881	CcSEcCtD
Protriptyline—Flushing—Cisplatin—esophageal cancer	0.000693	0.00876	CcSEcCtD
Protriptyline—Desipramine—CYP2A6—esophageal cancer	0.000689	0.132	CrCbGaD
Protriptyline—Arrhythmia—Cisplatin—esophageal cancer	0.000667	0.00844	CcSEcCtD
Protriptyline—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000663	0.0127	CbGpPWpGaD
Protriptyline—Alopecia—Cisplatin—esophageal cancer	0.00066	0.00835	CcSEcCtD
Protriptyline—Pancytopenia—Capecitabine—esophageal cancer	0.000653	0.00826	CcSEcCtD
Protriptyline—SLC6A4—Circadian rythm related genes—CRTC1—esophageal cancer	0.000651	0.0125	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—SLC39A6—esophageal cancer	0.000645	0.0124	CbGpPWpGaD
Protriptyline—Nortriptyline—PTGS1—esophageal cancer	0.000641	0.123	CrCbGaD
Protriptyline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000631	0.0121	CbGpPWpGaD
Protriptyline—Weight increased—Capecitabine—esophageal cancer	0.000626	0.00792	CcSEcCtD
Protriptyline—Phenylbutazone—PTGS2—esophageal cancer	0.000623	0.119	CrCbGaD
Protriptyline—SLC6A2—NRF2 pathway—ADH7—esophageal cancer	0.000615	0.0118	CbGpPWpGaD
Protriptyline—Vision blurred—Cisplatin—esophageal cancer	0.000613	0.00775	CcSEcCtD
Protriptyline—Tremor—Cisplatin—esophageal cancer	0.000609	0.0077	CcSEcCtD
Protriptyline—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000604	0.00764	CcSEcCtD
Protriptyline—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000604	0.00764	CcSEcCtD
Protriptyline—ABCB1—ABC-family proteins mediated transport—ABCC2—esophageal cancer	0.000603	0.0116	CbGpPWpGaD
Protriptyline—Ill-defined disorder—Cisplatin—esophageal cancer	0.000603	0.00763	CcSEcCtD
Protriptyline—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000601	0.0076	CcSEcCtD
Protriptyline—Myocardial infarction—Capecitabine—esophageal cancer	0.000601	0.0076	CcSEcCtD
Protriptyline—Jaundice—Capecitabine—esophageal cancer	0.000598	0.00756	CcSEcCtD
Protriptyline—Stomatitis—Capecitabine—esophageal cancer	0.000598	0.00756	CcSEcCtD
Protriptyline—Malaise—Cisplatin—esophageal cancer	0.000586	0.00741	CcSEcCtD
Protriptyline—Leukopenia—Cisplatin—esophageal cancer	0.000582	0.00736	CcSEcCtD
Protriptyline—Agranulocytosis—Capecitabine—esophageal cancer	0.000572	0.00724	CcSEcCtD
Protriptyline—CYP2D6—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.000564	0.0108	CbGpPWpGaD
Protriptyline—Convulsion—Cisplatin—esophageal cancer	0.000563	0.00712	CcSEcCtD
Protriptyline—Ataxia—Methotrexate—esophageal cancer	0.000557	0.00704	CcSEcCtD
Protriptyline—Anxiety—Cisplatin—esophageal cancer	0.000551	0.00697	CcSEcCtD
Protriptyline—Hypoaesthesia—Capecitabine—esophageal cancer	0.000548	0.00693	CcSEcCtD
Protriptyline—Discomfort—Cisplatin—esophageal cancer	0.000547	0.00692	CcSEcCtD
Protriptyline—Oedema—Cisplatin—esophageal cancer	0.000531	0.00671	CcSEcCtD
Protriptyline—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00053	0.0102	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—ABCC2—esophageal cancer	0.00052	0.00998	CbGpPWpGaD
Protriptyline—Thrombocytopenia—Cisplatin—esophageal cancer	0.000519	0.00657	CcSEcCtD
Protriptyline—Maprotiline—ABCB1—esophageal cancer	0.000519	0.0993	CrCbGaD
Protriptyline—Tachycardia—Cisplatin—esophageal cancer	0.000518	0.00655	CcSEcCtD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.000514	0.00987	CbGpPWpGaD
Protriptyline—Tinnitus—Capecitabine—esophageal cancer	0.000513	0.00649	CcSEcCtD
Protriptyline—Flushing—Capecitabine—esophageal cancer	0.000511	0.00646	CcSEcCtD
Protriptyline—Eosinophilia—Methotrexate—esophageal cancer	0.000507	0.00641	CcSEcCtD
Protriptyline—Anorexia—Cisplatin—esophageal cancer	0.000506	0.0064	CcSEcCtD
Protriptyline—Hypotension—Cisplatin—esophageal cancer	0.000496	0.00627	CcSEcCtD
Protriptyline—Arrhythmia—Capecitabine—esophageal cancer	0.000492	0.00622	CcSEcCtD
Protriptyline—Alopecia—Capecitabine—esophageal cancer	0.000486	0.00615	CcSEcCtD
Protriptyline—Pancytopenia—Methotrexate—esophageal cancer	0.000486	0.00615	CcSEcCtD
Protriptyline—SLC6A4—NRF2 pathway—NFE2L2—esophageal cancer	0.000483	0.00928	CbGpPWpGaD
Protriptyline—Paraesthesia—Cisplatin—esophageal cancer	0.000476	0.00602	CcSEcCtD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.000475	0.00911	CbGpPWpGaD
Protriptyline—Erectile dysfunction—Methotrexate—esophageal cancer	0.000471	0.00596	CcSEcCtD
Protriptyline—Dysgeusia—Capecitabine—esophageal cancer	0.000469	0.00593	CcSEcCtD
Protriptyline—Decreased appetite—Cisplatin—esophageal cancer	0.000461	0.00583	CcSEcCtD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.000458	0.0088	CbGpPWpGaD
Protriptyline—Drowsiness—Methotrexate—esophageal cancer	0.000456	0.00577	CcSEcCtD
Protriptyline—Vision blurred—Capecitabine—esophageal cancer	0.000452	0.00571	CcSEcCtD
Protriptyline—Tremor—Capecitabine—esophageal cancer	0.000449	0.00568	CcSEcCtD
Protriptyline—SLC6A2—NRF2 pathway—ABCC2—esophageal cancer	0.000447	0.00858	CbGpPWpGaD
Protriptyline—Stomatitis—Methotrexate—esophageal cancer	0.000445	0.00563	CcSEcCtD
Protriptyline—Ill-defined disorder—Capecitabine—esophageal cancer	0.000445	0.00562	CcSEcCtD
Protriptyline—Feeling abnormal—Cisplatin—esophageal cancer	0.000437	0.00553	CcSEcCtD
Protriptyline—CYP2D6—Melatonin metabolism and effects—CYP1B1—esophageal cancer	0.000436	0.00836	CbGpPWpGaD
Protriptyline—Malaise—Capecitabine—esophageal cancer	0.000432	0.00547	CcSEcCtD
Protriptyline—Leukopenia—Capecitabine—esophageal cancer	0.000429	0.00542	CcSEcCtD
Protriptyline—Agranulocytosis—Methotrexate—esophageal cancer	0.000426	0.00539	CcSEcCtD
Protriptyline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000424	0.00814	CbGpPWpGaD
Protriptyline—Palpitations—Capecitabine—esophageal cancer	0.000423	0.00536	CcSEcCtD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000422	0.00809	CbGpPWpGaD
Protriptyline—Body temperature increased—Cisplatin—esophageal cancer	0.000419	0.0053	CcSEcCtD
Protriptyline—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000418	0.00803	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—CYP2A6—esophageal cancer	0.000416	0.00798	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—NFE2L2—esophageal cancer	0.000416	0.00798	CbGpPWpGaD
Protriptyline—Hypertension—Capecitabine—esophageal cancer	0.000414	0.00523	CcSEcCtD
Protriptyline—Anxiety—Capecitabine—esophageal cancer	0.000407	0.00514	CcSEcCtD
Protriptyline—SLC6A2—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000406	0.0078	CbGpPWpGaD
Protriptyline—Discomfort—Capecitabine—esophageal cancer	0.000403	0.0051	CcSEcCtD
Protriptyline—Dry mouth—Capecitabine—esophageal cancer	0.000399	0.00505	CcSEcCtD
Protriptyline—Confusional state—Capecitabine—esophageal cancer	0.000394	0.00499	CcSEcCtD
Protriptyline—Oedema—Capecitabine—esophageal cancer	0.000391	0.00495	CcSEcCtD
Protriptyline—Thrombocytopenia—Capecitabine—esophageal cancer	0.000383	0.00484	CcSEcCtD
Protriptyline—Tinnitus—Methotrexate—esophageal cancer	0.000382	0.00483	CcSEcCtD
Protriptyline—Tachycardia—Capecitabine—esophageal cancer	0.000382	0.00483	CcSEcCtD
Protriptyline—Asthenia—Cisplatin—esophageal cancer	0.000381	0.00481	CcSEcCtD
Protriptyline—Carbamazepine—ABCB1—esophageal cancer	0.000378	0.0724	CrCbGaD
Protriptyline—Anorexia—Capecitabine—esophageal cancer	0.000373	0.00471	CcSEcCtD
Protriptyline—SLC6A2—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000372	0.00714	CbGpPWpGaD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00037	0.0071	CbGpPWpGaD
Protriptyline—Hypotension—Capecitabine—esophageal cancer	0.000365	0.00462	CcSEcCtD
Protriptyline—Diarrhoea—Cisplatin—esophageal cancer	0.000363	0.00459	CcSEcCtD
Protriptyline—Alopecia—Methotrexate—esophageal cancer	0.000362	0.00458	CcSEcCtD
Protriptyline—SLC6A2—NRF2 pathway—CYP2A6—esophageal cancer	0.000357	0.00686	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—SST—esophageal cancer	0.000356	0.00684	CbGpPWpGaD
Protriptyline—Insomnia—Capecitabine—esophageal cancer	0.000354	0.00447	CcSEcCtD
Protriptyline—Paraesthesia—Capecitabine—esophageal cancer	0.000351	0.00444	CcSEcCtD
Protriptyline—Dysgeusia—Methotrexate—esophageal cancer	0.000349	0.00442	CcSEcCtD
Protriptyline—Dyspepsia—Capecitabine—esophageal cancer	0.000344	0.00435	CcSEcCtD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000344	0.0066	CbGpPWpGaD
Protriptyline—Decreased appetite—Capecitabine—esophageal cancer	0.00034	0.0043	CcSEcCtD
Protriptyline—Vomiting—Cisplatin—esophageal cancer	0.000337	0.00427	CcSEcCtD
Protriptyline—Fatigue—Capecitabine—esophageal cancer	0.000337	0.00426	CcSEcCtD
Protriptyline—Vision blurred—Methotrexate—esophageal cancer	0.000336	0.00425	CcSEcCtD
Protriptyline—Rash—Cisplatin—esophageal cancer	0.000334	0.00423	CcSEcCtD
Protriptyline—Constipation—Capecitabine—esophageal cancer	0.000334	0.00423	CcSEcCtD
Protriptyline—Dermatitis—Cisplatin—esophageal cancer	0.000334	0.00423	CcSEcCtD
Protriptyline—Ill-defined disorder—Methotrexate—esophageal cancer	0.000331	0.00419	CcSEcCtD
Protriptyline—Feeling abnormal—Capecitabine—esophageal cancer	0.000322	0.00408	CcSEcCtD
Protriptyline—Malaise—Methotrexate—esophageal cancer	0.000322	0.00407	CcSEcCtD
Protriptyline—Leukopenia—Methotrexate—esophageal cancer	0.000319	0.00404	CcSEcCtD
Protriptyline—Nausea—Cisplatin—esophageal cancer	0.000315	0.00399	CcSEcCtD
Protriptyline—Urticaria—Capecitabine—esophageal cancer	0.000311	0.00393	CcSEcCtD
Protriptyline—Body temperature increased—Capecitabine—esophageal cancer	0.000309	0.00391	CcSEcCtD
Protriptyline—Abdominal pain—Capecitabine—esophageal cancer	0.000309	0.00391	CcSEcCtD
Protriptyline—Convulsion—Methotrexate—esophageal cancer	0.000309	0.00391	CcSEcCtD
Protriptyline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000302	0.0058	CbGpPWpGaD
Protriptyline—Discomfort—Methotrexate—esophageal cancer	0.0003	0.00379	CcSEcCtD
Protriptyline—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000298	0.00572	CbGpPWpGaD
Protriptyline—Confusional state—Methotrexate—esophageal cancer	0.000294	0.00371	CcSEcCtD
Protriptyline—SLC6A4—NRF2 pathway—TGFBR2—esophageal cancer	0.000291	0.00559	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—HMOX1—esophageal cancer	0.000287	0.00552	CbGpPWpGaD
Protriptyline—Thrombocytopenia—Methotrexate—esophageal cancer	0.000285	0.0036	CcSEcCtD
Protriptyline—SLC6A4—Circadian rythm related genes—GHRL—esophageal cancer	0.000284	0.00544	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—ENO1—esophageal cancer	0.000282	0.00541	CbGpPWpGaD
Protriptyline—Asthenia—Capecitabine—esophageal cancer	0.000281	0.00355	CcSEcCtD
Protriptyline—Anorexia—Methotrexate—esophageal cancer	0.000277	0.00351	CcSEcCtD
Protriptyline—Pruritus—Capecitabine—esophageal cancer	0.000277	0.0035	CcSEcCtD
Protriptyline—Hypotension—Methotrexate—esophageal cancer	0.000272	0.00344	CcSEcCtD
Protriptyline—Diarrhoea—Capecitabine—esophageal cancer	0.000268	0.00338	CcSEcCtD
Protriptyline—Insomnia—Methotrexate—esophageal cancer	0.000263	0.00333	CcSEcCtD
Protriptyline—Paraesthesia—Methotrexate—esophageal cancer	0.000261	0.00331	CcSEcCtD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00026	0.005	CbGpPWpGaD
Protriptyline—Somnolence—Methotrexate—esophageal cancer	0.000259	0.00327	CcSEcCtD
Protriptyline—Dizziness—Capecitabine—esophageal cancer	0.000259	0.00327	CcSEcCtD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—esophageal cancer	0.000258	0.00496	CbGpPWpGaD
Protriptyline—Desipramine—ABCB1—esophageal cancer	0.000257	0.0491	CrCbGaD
Protriptyline—Dyspepsia—Methotrexate—esophageal cancer	0.000256	0.00324	CcSEcCtD
Protriptyline—Decreased appetite—Methotrexate—esophageal cancer	0.000253	0.0032	CcSEcCtD
Protriptyline—Fatigue—Methotrexate—esophageal cancer	0.000251	0.00317	CcSEcCtD
Protriptyline—SLC6A2—NRF2 pathway—TGFBR2—esophageal cancer	0.000251	0.00481	CbGpPWpGaD
Protriptyline—Vomiting—Capecitabine—esophageal cancer	0.000249	0.00314	CcSEcCtD
Protriptyline—SLC6A2—NRF2 pathway—HMOX1—esophageal cancer	0.000247	0.00474	CbGpPWpGaD
Protriptyline—Rash—Capecitabine—esophageal cancer	0.000247	0.00312	CcSEcCtD
Protriptyline—Dermatitis—Capecitabine—esophageal cancer	0.000246	0.00312	CcSEcCtD
Protriptyline—Headache—Capecitabine—esophageal cancer	0.000245	0.0031	CcSEcCtD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000245	0.0047	CbGpPWpGaD
Protriptyline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000243	0.00467	CbGpPWpGaD
Protriptyline—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00024	0.00461	CbGpPWpGaD
Protriptyline—Feeling abnormal—Methotrexate—esophageal cancer	0.00024	0.00303	CcSEcCtD
Protriptyline—Nausea—Capecitabine—esophageal cancer	0.000232	0.00294	CcSEcCtD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000232	0.00446	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000232	0.00445	CbGpPWpGaD
Protriptyline—Urticaria—Methotrexate—esophageal cancer	0.000231	0.00292	CcSEcCtD
Protriptyline—Body temperature increased—Methotrexate—esophageal cancer	0.00023	0.00291	CcSEcCtD
Protriptyline—Abdominal pain—Methotrexate—esophageal cancer	0.00023	0.00291	CcSEcCtD
Protriptyline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000229	0.00439	CbGpPWpGaD
Protriptyline—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000226	0.00434	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—ADH7—esophageal cancer	0.000224	0.0043	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.000224	0.00429	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000218	0.00418	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000214	0.00411	CbGpPWpGaD
Protriptyline—Asthenia—Methotrexate—esophageal cancer	0.000209	0.00264	CcSEcCtD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000207	0.00397	CbGpPWpGaD
Protriptyline—Pruritus—Methotrexate—esophageal cancer	0.000206	0.0026	CcSEcCtD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—HMOX1—esophageal cancer	0.000205	0.00394	CbGpPWpGaD
Protriptyline—Diarrhoea—Methotrexate—esophageal cancer	0.000199	0.00252	CcSEcCtD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000197	0.00379	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—SMAD4—esophageal cancer	0.000197	0.00378	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000197	0.00378	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—ADH1B—esophageal cancer	0.000196	0.00377	CbGpPWpGaD
Protriptyline—Dizziness—Methotrexate—esophageal cancer	0.000193	0.00243	CcSEcCtD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000189	0.00363	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000189	0.00363	CbGpPWpGaD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000186	0.00356	CbGpPWpGaD
Protriptyline—Vomiting—Methotrexate—esophageal cancer	0.000185	0.00234	CcSEcCtD
Protriptyline—Rash—Methotrexate—esophageal cancer	0.000184	0.00232	CcSEcCtD
Protriptyline—Dermatitis—Methotrexate—esophageal cancer	0.000183	0.00232	CcSEcCtD
Protriptyline—CYP2D6—Biological oxidations—CYP26A1—esophageal cancer	0.000183	0.0035	CbGpPWpGaD
Protriptyline—Headache—Methotrexate—esophageal cancer	0.000182	0.00231	CcSEcCtD
Protriptyline—CYP2D6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00018	0.00346	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000175	0.00336	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000174	0.00333	CbGpPWpGaD
Protriptyline—Nausea—Methotrexate—esophageal cancer	0.000173	0.00219	CcSEcCtD
Protriptyline—CYP2D6—Biological oxidations—GSTO1—esophageal cancer	0.00017	0.00326	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—GSTO1—esophageal cancer	0.000167	0.00321	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	0.000161	0.0031	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—NOS2—esophageal cancer	0.000159	0.00305	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	0.000147	0.00282	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000143	0.00275	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.000138	0.00266	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	0.000132	0.00253	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.000132	0.00253	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.00013	0.0025	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00013	0.00249	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000123	0.00237	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000119	0.00229	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.000118	0.00227	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—CASP8—esophageal cancer	0.000115	0.0022	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000108	0.00207	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000105	0.00201	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000103	0.00199	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000103	0.00197	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000102	0.00196	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	9.92e-05	0.00191	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	9.86e-05	0.00189	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—EP300—esophageal cancer	9.72e-05	0.00187	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	9.72e-05	0.00187	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	9.59e-05	0.00184	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	9.09e-05	0.00175	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	8.97e-05	0.00172	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	8.7e-05	0.00167	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	8.68e-05	0.00167	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	8.42e-05	0.00162	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.32e-05	0.0016	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.32e-05	0.0016	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	7.97e-05	0.00153	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	7.91e-05	0.00152	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	7.6e-05	0.00146	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—TP53—esophageal cancer	6.96e-05	0.00134	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.3e-05	0.00121	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.72e-05	0.0011	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	5.66e-05	0.00109	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	5.63e-05	0.00108	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—BLVRB—esophageal cancer	5.62e-05	0.00108	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—SLC52A3—esophageal cancer	5.62e-05	0.00108	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—SLC52A3—esophageal cancer	5.3e-05	0.00102	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—BLVRB—esophageal cancer	5.3e-05	0.00102	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.08e-05	0.000975	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	4.85e-05	0.000932	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—SLC10A2—esophageal cancer	4.78e-05	0.000918	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CA1—esophageal cancer	4.78e-05	0.000918	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	4.72e-05	0.000905	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	4.61e-05	0.000885	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CA1—esophageal cancer	4.5e-05	0.000865	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—SLC10A2—esophageal cancer	4.5e-05	0.000865	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CA2—esophageal cancer	4.37e-05	0.000839	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	4.17e-05	0.0008	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CA2—esophageal cancer	4.12e-05	0.000791	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PLCE1—esophageal cancer	4.06e-05	0.00078	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—ADH7—esophageal cancer	4.06e-05	0.00078	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	4.03e-05	0.000774	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.83e-05	0.000736	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ADH7—esophageal cancer	3.83e-05	0.000735	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PLCE1—esophageal cancer	3.83e-05	0.000735	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—ADH1B—esophageal cancer	3.56e-05	0.000684	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.48e-05	0.000669	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—TYMP—esophageal cancer	3.41e-05	0.000654	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ADH1B—esophageal cancer	3.36e-05	0.000645	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.34e-05	0.000642	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CYP26A1—esophageal cancer	3.31e-05	0.000636	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.27e-05	0.000628	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—ALOX15—esophageal cancer	3.23e-05	0.00062	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—TYMP—esophageal cancer	3.21e-05	0.000616	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CYP26A1—esophageal cancer	3.12e-05	0.000599	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GSTO1—esophageal cancer	3.08e-05	0.000591	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—TPI1—esophageal cancer	3.08e-05	0.000591	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ALOX15—esophageal cancer	3.04e-05	0.000584	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—ALDOB—esophageal cancer	2.95e-05	0.000567	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GSTO1—esophageal cancer	2.9e-05	0.000557	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—TPI1—esophageal cancer	2.9e-05	0.000557	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GAPDH—esophageal cancer	2.84e-05	0.000546	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.84e-05	0.000545	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CRABP1—esophageal cancer	2.82e-05	0.000541	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ALDOB—esophageal cancer	2.78e-05	0.000534	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.74e-05	0.000527	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GNG7—esophageal cancer	2.68e-05	0.000514	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GAPDH—esophageal cancer	2.68e-05	0.000514	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CRABP1—esophageal cancer	2.65e-05	0.00051	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GNG7—esophageal cancer	2.52e-05	0.000485	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—ALDH2—esophageal cancer	2.51e-05	0.000482	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GSTT1—esophageal cancer	2.39e-05	0.000458	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.37e-05	0.000454	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.36e-05	0.000453	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GSTT1—esophageal cancer	2.25e-05	0.000432	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—ENO1—esophageal cancer	2.24e-05	0.00043	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PTGS1—esophageal cancer	2.24e-05	0.00043	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.24e-05	0.000429	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CYP2A6—esophageal cancer	2.22e-05	0.000427	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PSME2—esophageal cancer	2.2e-05	0.000423	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PSME1—esophageal cancer	2.2e-05	0.000423	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ENO1—esophageal cancer	2.11e-05	0.000405	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.11e-05	0.000405	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PSME2—esophageal cancer	2.08e-05	0.000399	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PSME1—esophageal cancer	2.08e-05	0.000399	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.9e-05	0.000365	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.79e-05	0.000344	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.79e-05	0.000343	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.69e-05	0.000324	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—HMOX1—esophageal cancer	1.63e-05	0.000313	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.54e-05	0.000295	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.48e-05	0.000283	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CREBBP—esophageal cancer	1.05e-05	0.000201	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CREBBP—esophageal cancer	9.87e-06	0.000189	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—NOS3—esophageal cancer	9.37e-06	0.00018	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—NOS3—esophageal cancer	8.83e-06	0.00017	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PTGS2—esophageal cancer	8.57e-06	0.000165	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PTGS2—esophageal cancer	8.08e-06	0.000155	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—EP300—esophageal cancer	7.13e-06	0.000137	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—EP300—esophageal cancer	6.72e-06	0.000129	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PIK3CA—esophageal cancer	5.28e-06	0.000101	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PIK3CA—esophageal cancer	4.97e-06	9.54e-05	CbGpPWpGaD
